Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation

被引:15
作者
Grobe, Nadja [1 ]
Kutchan, Toni M. [1 ]
Zenk, Meinhart H. [1 ]
机构
[1] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA
基金
美国国家卫生研究院;
关键词
CYP2D6; CYP2D1 and CYP2D2; Mammalian morphine biosynthesis; LC-MS/MS analysis; DARK AGOUTI RATS; SPRAGUE-DAWLEY; O-DEMETHYLATION; MOLECULAR-BASIS; METABOLISM; SALUTARIDINE; BIOSYNTHESIS; POLYMORPHISM; OXIDATION; ISOFORMS;
D O I
10.1016/j.febslet.2012.05.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The assumption that CYP2D1 is the corresponding rat cytochrome to human CYP2D6 has been revisited using recombinant proteins in direct enzyme assays. CYP2D1 and 2D2 were incubated with known CYP2D6 substrates, the three morphine precursors thebaine, codeine and (R)-reticuline. Mass spectrometric analysis showed that rat CYP2D2, not 2D1, catalyzed the 3-O-demethylation reaction of thebaine and codeine. In addition, CYP2D2 incubated with (R)-reticuline generated four products corytuberine, pallidine, salutaridine and isoboldine while rat CYP2D1 was completely inactive. This intramolecular phenol-coupling reaction follows the same mechanism as observed for CYP2D6. Michaelis-Menten kinetic parameters revealed high catalytic efficiencies for rat CYP2D2. These findings suggest a critical evaluation of other commonly accepted, however untested, CYP2D1 substrates. (C) 2012 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:1749 / 1753
页数:5
相关论文
共 20 条
[1]   AN EVALUATION OF CYTOCHROME-P450 ISOFORM ACTIVITIES IN THE FEMALE DARK AGOUTI (DA) RAT - RELEVANCE TO ITS USE AS A MODEL OF THE CYP2D6 POOR METABOLIZER PHENOTYPE [J].
BARHAM, HM ;
LENNARD, MS ;
TUCKER, GT .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (08) :1295-1307
[2]   The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study [J].
Bromek, Ewa ;
Haduch, Anna ;
Daniel, Wladyslawa A. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 626 (2-3) :171-178
[3]   Endogenous morphine-like compound immunoreactivity increases in parkinsonism [J].
Charron, Giselle ;
Doudnikoff, Evelyne ;
Laux, Alexis ;
Berthet, Amandine ;
Porras, Gregory ;
Canron, Marie-Helene ;
Barroso-Chinea, Pedro ;
Li, Qin ;
Qin, Chuan ;
Nosten-Bertrand, Marika ;
Giros, Bruno ;
Delalande, Francois ;
Van Dorsselaer, Alain ;
Vital, Anne ;
Goumon, Yannick ;
Bezard, Erwan .
BRAIN, 2011, 134 :2321-2338
[4]   THE GENETIC-POLYMORPHISM OF DEBRISOQUINE SPARTEINE METABOLISM - CLINICAL ASPECTS [J].
EICHELBAUM, M ;
GROSS, AS .
PHARMACOLOGY & THERAPEUTICS, 1990, 46 (03) :377-394
[5]   Pharmacogenomics: Translating functional genomics into rational therapeutics [J].
Evans, WE ;
Relling, MV .
SCIENCE, 1999, 286 (5439) :487-491
[6]  
GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q
[7]   CYP719B1 Is Salutaridine Synthase, the C-C Phenol-coupling Enzyme of Morphine Biosynthesis in Opium Poppy [J].
Gesell, Andreas ;
Rolf, Megan ;
Ziegler, Joerg ;
Chavez, Maria Luisa Diaz ;
Huang, Fong-Chin ;
Kutchan, Toni M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (36) :24432-24442
[8]   Mammalian Cytochrome P450 Enzymes Catalyze the Phenol-coupling Step in Endogenous Morphine Biosynthesis [J].
Grobe, Nadja ;
Zhang, Baichen ;
Fisinger, Ursula ;
Kutchan, Toni M. ;
Zenk, Meinhart H. ;
Guengerich, F. Peter .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (36) :24425-24431
[9]  
Guengerich F.P., 1995, CYTOCHROME P450 STRU, P473
[10]   Catalytic specificity of CYP2D isoforms in rat and human [J].
Hiroi, T ;
Chow, T ;
Imaoka, S ;
Funae, Y .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (09) :970-976